Phase II trial of PS341 (NSC 681239) in patients with advanced renal cell carcinoma
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2009
At a glance
- Drugs Bortezomib (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 22 Dec 2009 Actual end date (April 2004) added as reported by ClinicalTrials.gov.
- 22 Dec 2009 Last checked against ClinicalTrials.gov record.
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.